These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 33227455)
1. Quality validation of platelets obtained from the Haemonetics and Trima Accel automated blood-collection systems. Wang HH; Liao LN; Lin CL; Yen LL; Hsiao YM; Ko JL Transfus Clin Biol; 2021 Feb; 28(1):44-50. PubMed ID: 33227455 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Plateletpheresis on the Haemonetics and Trima Accel Cell Separators. Keklik M; Keklik E; Kalan U; Ozer O; Arik F; Sarikoc M Ther Apher Dial; 2018 Feb; 22(1):87-90. PubMed ID: 29082642 [TBL] [Abstract][Full Text] [Related]
3. Comparative assessment of single-donor plateletpheresis by Haemonetics Baruah S; Bajpai M Asian J Transfus Sci; 2020; 14(1):23-27. PubMed ID: 33162701 [TBL] [Abstract][Full Text] [Related]
4. Effectiveness of the Trima Accel cell separator in the double dose plateletpheresis. Keklik M; Korkmaz S; Kalan U; Sarikoc M; Keklik E Transfus Apher Sci; 2016 Oct; 55(2):240-242. PubMed ID: 27522105 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of five plateletpheresis machines in a tertiary care center of India: AmiCORE vs COM.TEC vs Haemonetics MCS+ vs Spectra Optia vs Trima Accel. Arcot PJ; Kumar K; Coshic P; Andriyas V; Mehta V J Clin Apher; 2021 Feb; 36(1):41-47. PubMed ID: 32894894 [TBL] [Abstract][Full Text] [Related]
6. Phosphatidylserine exposure in platelet concentrates during the storage period: differences between the platelets collected with different cell separators. Lai M; Rumi C; D'Onofrio G; Puggioni PL; Menichella G; Candido A; Leone G Transfus Apher Sci; 2002 Dec; 27(3):239-45. PubMed ID: 12509219 [TBL] [Abstract][Full Text] [Related]
7. Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS). Slichter SJ; Corson J; Jones MK; Christoffel T; Pellham E; Bailey SL; Bolgiano D Blood; 2014 Jan; 123(2):271-80. PubMed ID: 24258816 [TBL] [Abstract][Full Text] [Related]
8. Comparison of double dose plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC and Trima Accel cell separators. Keklik M; Eser B; Kaynar L; Solmaz M; Ozturk A; Yay M; Birekul A; Oztekin M; Sivgin S; Cetin M; Unal A Transfus Apher Sci; 2014 Oct; 51(2):193-6. PubMed ID: 25219639 [TBL] [Abstract][Full Text] [Related]
9. First comparison of productivity and citrate donor load between the Trima version 4 (dual-stage filler) and the Trima Accel (single-stage filler) in the same donors. Ringwald J; Zingsem J; Zimmermann R; Strasser E; Antoon M; Eckstein R Vox Sang; 2003 Nov; 85(4):267-75. PubMed ID: 14633252 [TBL] [Abstract][Full Text] [Related]
10. Apheresis technology correlates with bacterial contamination of platelets and reported septic transfusion reactions. Eder AF; Dy BA; DeMerse B; Wagner SJ; Stramer SL; O'Neill EM; Herron RM Transfusion; 2017 Dec; 57(12):2969-2976. PubMed ID: 28880363 [TBL] [Abstract][Full Text] [Related]
11. Comparison of plateletpheresis on the Fenwal Amicus, Fresenius COM.TEC, and Trima Accel Cell separators. Keklik M; Eser B; Kaynar L; Sivgin S; Keklik E; Solmaz M; Ozturk A; Buyukoglan R; Yay M; Cetin M; Unal A J Clin Apher; 2015 Jun; 30(3):171-5. PubMed ID: 25230340 [TBL] [Abstract][Full Text] [Related]
12. The quality of platelet concentrates produced by COBE Spectra and Trima Accel cell separators during storage for 7 days as assessed by in vitro methods. Tynngård N; Lindahl TL; Trinks M; Studer M; Berlin G Transfusion; 2008 Apr; 48(4):715-22. PubMed ID: 18208416 [TBL] [Abstract][Full Text] [Related]
13. Markers of platelet activation and apoptosis in platelet concentrates collected by apheresis. Procházková R; Andrýs C; Hubácková L; Krejsek J Transfus Apher Sci; 2007 Oct; 37(2):115-23. PubMed ID: 17945536 [TBL] [Abstract][Full Text] [Related]
14. Immature Platelet Count Levels as a Novel Quality Marker in Plateletpheresis. Unay Demirel O; Ignak S; Buyukuysal MC Indian J Hematol Blood Transfus; 2018 Oct; 34(4):684-690. PubMed ID: 30369741 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the platelet activation status of single-donor platelets obtained with two different cell separator technologies. Millar D; Hayes C; Jones J; Klapper E; Kniep JN; Luu HS; Noland DK; Petitti L; Poisson JL; Spaepen E; Ye Z; Maurer-Spurej E Transfusion; 2020 Sep; 60(9):2067-2078. PubMed ID: 32729161 [TBL] [Abstract][Full Text] [Related]
16. Comparison of platelet quality and function across apheresis collection platforms. Thomas KA; Srinivasan AJ; McIntosh C; Rahn K; Kelly S; McGough L; Clayton S; Perez S; Smith A; Vavro L; Musgrove J; Hill R; Mdaki KS; Bynum JA; Meledeo MA; Cap AP; Spinella PC; Reddoch-Cardenas KM; Shea SM Transfusion; 2023 May; 63 Suppl 3():S146-S158. PubMed ID: 37070399 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution. Johnson L; Winter KM; Hartkopf-Theis T; Reid S; Kwok M; Marks DC Transfusion; 2012 Mar; 52(3):503-9. PubMed ID: 21880041 [TBL] [Abstract][Full Text] [Related]
18. Postdonation platelet counts are safe when collecting platelets with the Trima Accel using a postdonation platelet count target of > or =50,000 platelets/microL. Alex J; Roberts B; Raife T J Clin Apher; 2009; 24(5):215-7. PubMed ID: 19816960 [TBL] [Abstract][Full Text] [Related]